Lipids, liver and pancreas at the crossroads of metabolic syndrome and obesity epidemics

Lipids, liver and pancreas at the crossroads of metabolic syndrome and obesity epidemics

The prevalence of metabolic syndrome (MS), non-alcoholic fatty liver disease (NAFLD) and non-alcoholic fatty pancreatic disease (NAFPD) is 1/4–1/3 of the planet population. It has been proven that the main links in their pathogenesis are disorders of lipid and carbohydrate metabolism. A high comorbi...

Full description

Bibliographic Details
Main Authors: O. V. Efimova, I. N. Grigor'eva, N. L. Tov, T. S. Suvorova, D. L. Nepomnyashchikh, T. I. Romanova
Format: Article
Language:Russian
Published: Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics 2020-12-01
Series:Атеросклероз
Subjects:
metabolic syndrome
non-alcoholic fatty pancreatic disease
non-alcoholic fatty liver disease
acute pancreatitis
chronic pancreatitis
blood lipids
Online Access:https://ateroskleroz.elpub.ru/jour/article/view/402/382

Similar Items

Similar Items